Q4 2025 earnings call highlights: 2026 revenue outlook, Bako/StrataDx deals, AI pathology gains, and customer-loss risks—read now.

Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. As a ...

Investigators in the Nancy Guthrie case have turned to genetic genealogy as they try to make the most of potential DNA ...

Researchers have found that a new base-editing gene therapy can help treat a rare neurodevelopmental disorder called Snijders Blok–Campeau syndrome caused by mutations in the CHD3 gene. A specialized ...

Analysts have lifted their price target for SOPHiA GENETICS by $1, signalling a slightly higher view of what the shares could reasonably be worth. That move is grounded in updated models, where more ...

U.S. policymakers addressing the public's concerns about how genetic information could be used, in different insurance-related contexts, should ...

Pasca Lab specializes in growing three-dimensional organoid models from reprogrammed stem cells, which capture molecular changes during fetal brain-like development. Because the human brain cannot be ...

As the search for 84-year-old Nancy Guthrie continues, legal questions around DNA testing to identify a suspect in Guthrie’s ...

Daphne O. Martschenko and Sam Trejo both want to make the world a better, fairer, more equitable place. But they disagree on whether studying social genomics—elucidating any potential genetic ...

As hopeful parents start their reproductive journeys, they may be offered a variety of tests and screenings, which can be ...

Q4 2025 earnings call recap: revenue beat, MyRisk/GeneSight growth, 2026 guidance, new test launches & key risks—read now.